
CAS 314045-39-1
:bis-2-(5-Phénylacétamido-1,2,4-Thiadiazol-2-yl)Éthyl Sulfure
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
BPTES
CAS :Formule :C24H24N6O2S3Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :524.6814BPTES
CAS :BPTES(IC50 of 0.16 μM) is an effective and specific GlutamiN/Ase GLS1 (KGA) inhibitor.Formule :C24H24N6O2S3Degré de pureté :95.83% - 99.64%Couleur et forme :Yellow SolidMasse moléculaire :524.68BPTES
CAS :N,N'-((Thiobis(ethane-2,1-diyl))bis(1,3,4-thiadiazole-5,2-diyl))bis(2-phenylacetamide)Formule :C24H24N6O2S3Degré de pureté :98%Masse moléculaire :524.68BIS-2-(5-PHENYLACETAMIDO-1,3,4-THIADIAZOL-2-YL)ETHYL SULFIDE
CAS :Degré de pureté :98%Masse moléculaire :524.6799927BPTES-d10
CAS :Produit contrôléApplications BPTES-d10 is the isotope labelled analog of BPTES (B676675); a potent and selective glutaminase inhibitor. Used in the treatment of renal cell carcinomas resulting from overexpression of the MYC oncogene.
References Shroff, E. et al.: PNAS. U.S.A., 112, 6539 (2015); Thomas, A. et al.: Biochem. Biophys. Res. Comm., 443, 32 (2014)Formule :C24D10H14N6O2S3Couleur et forme :NeatMasse moléculaire :534.743BPTES
CAS :Produit contrôléApplications BPTES is a potent and selective Glutaminase inhibitor. Used in the treatment of renal cell carcinomas resulting from overexpression of the MYC oncogene.
References Shroff, E. et al.: PNAS. U.S.A., 112, 6539 (2015); Thomas, A. et al.: Biochem. Biophys. Res. Comm., 443, 32 (2014);Formule :C24H24N6O2S3Couleur et forme :NeatMasse moléculaire :524.68Glutaminase Inhibitor II, BPTES
CAS :The Glutaminase Inhibitor II, BPTES is a glutaminase inhibitor that is used to treat cancer. It binds to the active site of glutaminase and inhibits the enzyme from catalyzing the conversion of glutamine to glutamate. This results in reduced production of ATP, which leads to cell death. The minimal toxicity of this drug has been shown in animal models using a dinucleotide phosphate-based assay. BPTES has also been shown to inhibit mitochondrial membrane potential and induce apoptosis by decreasing levels of reactive oxygen species (ROS) and increasing mitochondrial membrane potential in a model system. BPTES can also synergize with other drugs such as anticancer agents or radiation therapy, resulting in increased efficacy against tumor cells.
Formule :C24H24N6O2S3Degré de pureté :Min. 95%Masse moléculaire :524.68 g/mol







